What: On June 1, 2025, the Employee Benefits Security Administration (EBSA) published a request for information (RFI) regarding the prescription drug machine-readable file disclosure requirements in the Transparency in Coverage (TiC) final rules. The Departments of Labor, Health and Human Services (HHS), and U.S. Treasury (the Departments) issued the RFI to gather input regarding implementation of the prescription drug machine-readable file disclosure requirements under the Transparency in Coverage final rules, including what modifications to the disclosure requirements or additional technical implementation guidance might be necessary to better ensure the accurate and timely completion of the prescription drug file.
Why: The Departments are soliciting information from the public to inform future rulemaking or guidance on prescription drug price transparency. The Departments intend to implement disclosure requirements related to prescription drug expenditures and effectuate the goals of greater price transparency, including transparency related to prescription drug pricing.
Action: The Departments now seek public comments on ways to effectively implement or amend the disclosure requirements related to prescription drug expenditures in the TiC final rules. Comments are due to EBSA on or before July 2, 2025.
Is your small business or entity being impacted by a proposed rule? If yes, write a comment letter to the proposing agency.